Clinical Follow-up to Evaluate the Clinical Usefulness of Gentamicin-coated Titanium Nails in Tibia Fractures
NCT ID: NCT01282294
Last Updated: 2015-03-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2011-02-28
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Coated and Non-coated Tibia Nails
NCT04576052
Focused Registry on the Titanium Trochanter Fixation Nail Advanced (TFNAdvanced™)
NCT02305121
DePuy Trochanteric (ATN) Nailing Clinical Outcomes Trial
NCT00546429
A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT
NCT04015128
A Study to Evaluate the Safety and Effectiveness of TRIGEN™ INTERTAN™ (10S Models)
NCT04865146
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ETN PROtect
There is only 1 cohort in this case series
ETN PROtect
Expert Tibial Nail PROtect with Gentamicin coating
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ETN PROtect
Expert Tibial Nail PROtect with Gentamicin coating
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Open or closed tibia fracture according to the surgical technique
Exclusion Criteria
* Patients with consumptive/ malignant primary disease and a life expectancy of \< 3 months
* Patients with a known allergy to aminoglycosides
* Physical or mental incapacity, which makes it impossible to obtain informed consent
* History of drug and alcohol abuse
* Patient unlikely to cooperate
* Legal incompetence
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Synthes GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael J. Raschke, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Münster, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité - Universitätsmedizin Berlin
Berlin, , Germany
Universitätsklinikum Freiburg
Freiburg im Breisgau, , Germany
Universitätsklinikum Heidelberg
Heidelberg, , Germany
University Hospital of Münster
Münster, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU-BIO-T-XX-190-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.